Activation of DDR1 contributes to tumorgenicity in PDAC [118] and selective, DDR1-specific kinase inhibitors can decrease cancer cell proliferation, invasion, and adhesion across several cancer models [118,119]. This evidence concerns the gene DDR1 and cancer.